tory brainstem responses (ABR) were recorded at baseline and on post inoculation day (pid) 7 and 14. A change of 30db or more was considered significant. To determine seroconversion after vaccination, sera were collected after the third vaccination. DNAemia was determined by real time PCR from whole blood collected pid 7. RESULTS: 4/5 (80%) of vaccinated animals demonstrated stable hearing on pid14 in the ear inoculated with virus while 4/4 (100%) of the control animals had worsened hearing. Animals in group A demonstrated seroconversion based on ELISA results while group B had a log higher viral titer based on real time PCR. CONCLUSION: Our study indicates that the glycoprotein B vaccine may have a protective role in CMV induced hearing loss. This warrants further investigation into the role of vaccine therapy for congenital CMV induced hearing loss.
Vein of Labbe Radiographic Anatomy: Surgical Implications
Nael Shoman, MD (presenter); Biraj Patel, MD; Ravi Samy, MD; Myles Pensak, MD; Mario Zuccarello, MD OBJECTIVE: 1) Understand the drainage patterns of the 3 largest superficial anastomotic veins (SAV): the vein of Labbe (VL), the vein of Trolard (VT), and the superficial Sylvian vein (SSV). 2) Be able to describe the importance of the VL and other SAV in neurotologic surgery, as their interruption may result in a venous infarct of the temporal lobe. METHOD: Between July 1984 and June 2009, all lateral skull base procedures that required temporal lobe retraction were reviewed to determine the incidence of temporal lobe venous infarcts. For the second part of this study, a retrospective review was then performed of all patients who underwent a diagnostic angiogram between September 1, 2009 and January 1, 2010. Studies were excluded if there were intracranial masses or vascular lesions. Angiograms were assessed for the presence of the VL, VT, and SSV, as well as vessel dominance, as determined by their relative calibers. RESULTS: Of 350 patients who underwent lateral skull base procedures requiring temporal lobe retraction, there were 4 temporal lobe venous infarcts. A total of 250 angiographic studies (81% were bilateral studies) were reviewed. The average age of the patients was 55 years (range: 16-83). Seventyseven patients (53%) were females. The most common pattern observed was the presence of all 3 SAV's (78%). The VL was absent or poorly developed in 34 studies (14%) and was the dominant superficial vein in 51 (20%), of which 28 (55%) occurred on the right. CONCLUSION: Lateral skull base procedures requiring temporal lobe retraction are associated with a Ͻ1% incidence of venous infarct. Considerable variability is demonstrated in the drainage patterns of the SAV's. Care should be taken in neu-rotologic surgery to avoid injuring the SAV, in particular the VL, as it may represent the single dominant drainage pathway of the lateral surface of the temporal lobe in a large number of patients.
Vestibular Evoked Myogenic Potentials: An Update
Ransith Mudduwa, MBBS, MRCS, DO-HNS (presenter); Naveed Kara, MBChB, MRCS, DOHNS OBJECTIVE: 1) To illustrate the evolution, practical aspects, and clinical applications of testing VEMPs. 2) To provide clarity on their use in clinical practice. METHOD: A comprehensive literature review was performed between November 2008 and April 2009, and results were limited to include clinical trials and review articles. A hand search through the reference lists of identified articles and textbooks was also undertaken to locate additional studies that could contribute to the review. RESULTS: Following their initial discovery, it was several years before the clinical significance of testing VEMPs was revisited. Much research has been conducted to date to determine a role for VEMPs in routine clinical practice, to explore the neural pathways and to establish the best method of testing VEMPs. The practical application of the test has been refined. There are varying degrees of evidence available on their use in many vestibular disorders. CONCLUSION: VEMPs are a simple non-invasive outpatient investigation for vestibular pathology. They are considered a diagnostic test in Superior Canal Dehiscence, but due to a lack of conclusive evidence, should still be used with caution in any other vestibular conditions.
Virtual Temporal Bone Training: The UK Experience
James Powles, FRCS (presenter) OBJECTIVE: To highlight the potential use of temporal bone simulators in otology training and the experience of the UK's first virtual mastoidectomy course. The structure of the course was novel: 'a journey through a mastoidectomy' taking participants from first consultation to eventual discharge. The regular use of the simulators in otology training will also be covered. METHOD: Outline of the experience. CONCLUSION: We have found the mastoid simulator to be an extremely useful adjunct to traditional training methods. The course highlighted the benefits of this type of training experience. Being able to 'rewind' while operating, realistic haptic feedback, unparalleled real-time comparisons with CT findings, the ability to remove structures to aid anatomical understanding and particularly the simulation of disease suggests that virtual temporal bones will play a role in future otology training. As the technology improves we feel that P253 Poster Presentations POSTERS concepts such as prospectively performing specific cases in a virtual setting will be invaluable for trainees, trainers and even experts.
WHO Ear and Hearing Survey-Ecuador 2009
Alejandra Ullauri, AuD (presenter); Andrew Smith, MBBS, MRCP, MSc; Rodrigo Castrillon, MD; Cesar Salazar, MD; Paul Garces, MD OBJECTIVE: First national study of prevalence of ear and hearing disorders conducted in Latin America which follows the World Health Organization Ear and Hearing Disorder Survey protocol. 1) Provide regional governments, institutions, and professionals with local and accurate information on the prevalence of ear and hearing pathologies in the Ecuadorian population. 2) Contribute to the global burden of disease by generating standardized data that can be compared among countries and regions. METHOD: Prospective, multi-stage cluster sample design study, conducted over a 9-month period (March to Dec 2009). Population tested: all members of households selected according to the sample strategy (cluster sample design, 28 clusters by population proportional to size in Ecuador). Testing was carried out in hospital facilities across the country including: audiometry/TEAOEs, and otological examination. Outcome measures: the diagnostic criteria for disabling hearing impairment established by the WHO. Data was entered in EARFORM software for basic statistical analysis and then compared to results obtained from contingency tables. RESULTS: 5762 subjects tested. The prevalence of hearing impairment (HI) in the adult population (15 yrs and older) was 6.4% with a CI of 5.6% to 7.2%. In the 4 to 14 yrs, 11 months age group was 1.7% with a CI of 1.1% to 2.3%. Out of the total population tested, 14.52% are in need of action or services. The prevalence of different ear pathologies and the total prevalence of HI including those under the age of 4 will be further discussed in the full paper. CONCLUSION: The prevalence of HI correlates with the prevalence found in other studies using the same protocol and it is under the 10% estimated by the WHO. The Ecuadorian population is in need of a substantial improvement in hearing services delivery.
Pediatric Otolaryngology

A Comparative Study of Evaluation of Adenoid Tissue Size
Priscila Novaes, MD (presenter) OBJECTIVE: To evaluate the correlation between the findings on radiographs of the cavum and nasal fiber optic examination in evaluation of adenoid tissue sizer in children moni-tored by the Department of Orthodontics of the College of Dentistry of the University Hospital Clementino Fraga Filho. METHOD: Nineteen patients between the ages of 8 and 13 years were selected and accompanied through services provided by the department of Orthodontics at HUCFF. All children underwent cavum radiography and nasal fiber optic examination. The reductions of the air column in the cavum radiographs were subjectively quantified in percentages for ear, nose, and throat physicians and then compared with the endoscopic results. RESULTS: In 15 patients evaluated, a correlation was found between the results from the cavum radiographies and the endoscopies (78%). Discrepancies occurred in results of 4 patients (22%). In 2 of these, the reduction of the caliber of the air column of the cavum super estimated endoscopic findings. In one patient, the radiological evaluation revealed a significant reduction of the air column of the cavum by increased soft tissue (80%), while endoscopy revealed adenoid tissue occupied only 30% of the rinofaringe. In another, the endoscopy revealed only remnants of adenoid tissue, while radiography showed a 50% reduction in the size of the air column of the cavum. In two patients the radiographs revealed the air column of the cavum evident with no reduction in its size, while the endoscope showed 30% of the lumen of the cavum had been occupied by adenoid tissue. CONCLUSION: There is a correlation between the findings of the paranasal sinuses radiography and endoscopy in the evaluation of adenoid tissue size in children.
A Human Hemangioma Culture System for Pharmaceutical Testing
Abby Meyer, MD (presenter); Ryan Fader; Beverly Wuertz; James Sidman, MD; Frank Ondrey, MD, PhD OBJECTIVE: 1) Develop a hemangioma tissue culture system for the analysis of putative drugs for hemangioma treatment. 2) Explore the effects of Imiquimod on cyclin D1 and Ki-67 protein expression in hemangioma cultures. METHOD: Fresh human hemangiomas were obtained from OR specimens and placed in tissue culture containing Fibrinogen Factor, MCDB131 medium, ⑀-aminocaproate, and thrombin. Tissues were treated with 0-25 uG/ml Imiquimod and stained for Cyclin D1 and Ki-67 by IHC. RESULTS: Reliable tissue sections were grown from two of three hemangiomas. 31 of 34 specimens (91.1%) grew and were stained. 22 of 31 specimens (71.0%) yielded sections with at least 100 evaluable cells. Cyclin D1 and Ki-67 labeling indices from 0 to 35% were identified. Statistical trends between pϭ 0.0425 and 0.1 (1 way ANOVA) were identified on Cyclin D1 or Ki-67 labeling indices between triplicate control or Imiquimod treated tissues at some concentrations. CONCLUSION: We conclude the following: 1) Hemangioma tissues can be grown in tissue culture and used for drug treat-
